RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2845-2856

  Yamada, Tamaki ^a,b   Tsuda, Masumi ^a   Takahashi, Tomomi ^b   Totsuka, Yasunori ^b   Shindoh, Masanobu ^b   Ohba, Yusuke ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; OSTEOCLAST DIFFERENTIATION FACTOR; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GINGIVA; HEAD AND NECK CARCINOMA; HINDLIMB; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INOCULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE; TUMOR DIFFERENTIATION; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 79959376164     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.003     Document Type: Article

References (68)

1. Albini A, Sporn MB: The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007, 7:139-147 (Pubitemid 46160989)
2. Joyce JA: Therapeutic targeting of the tumor microenvironment. Cancer Cell 2005, 7:513-520 (Pubitemid 40799245)
3. Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 2008, 9:239-252
4. Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature 2001, 411:375-379
5. Massagué J: TGFbeta in cancer. Cell 2008, 134:215-230
6. Orimo A, Weinberg RA: Stromal fibroblasts in cancer: a novel tumorpromoting cell type. Cell Cycle 2006, 5:1597-1601 (Pubitemid 44285243)
7. Polyak K, Haviv I, Campbell IG: Co-evolution of tumor cells and their microenvironment. Trends Genet 2009, 25:30-38
8. Chen AY, Myers JN: Cancer of the oral cavity. Dis Mon 2001, 47:275-361
9. Whiteside ST, Israël A: I kappa B proteins: structure, function and regulation. Semin Cancer Biol 1997, 8:75-82 (Pubitemid 27412323)
10. Reichart PA: Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Investig 2001, 5:207-213
11. Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM: Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999)-Recent trends and regional variation. Oral Oncol 2006, 42:586-592 (Pubitemid 43965006)
12. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S: An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004, 40:304-313 (Pubitemid 38121568)
13. Popovtzer A, Shpitzer T, Bahar G, Marshak G, Ulanovski D, Feinmesser R: Squamous cell carcinoma of the oral tongue in young patients. Laryngoscope 2004, 114:915-917 (Pubitemid 38625549)
14. Shiboski CH, Schmidt BL, Jordan RC: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005, 103:1843-1849 (Pubitemid 40563256)
15. Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H, Sato M: Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol 2006, 29:1133-1138
16. Chang JY, Wright JM, Svoboda KK: Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers. Cells Tissues Organs 2007, 185:40-47 (Pubitemid 46956841)
17. Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995, 154:8-20 (Pubitemid 26101385)
18. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition [Erratum appeared in J Clin Invest 2010;120:1786]. J Clin Invest 2009, 119:1420-1428
19. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003, 15:740-746 (Pubitemid 37487967)
20. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454
21. Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, Mikulits W: Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004, 566:9-20 (Pubitemid 38045586)
22. Thiery JP, Sleeman JP: Complex networks orchestrate epithelialmesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142 (Pubitemid 43278296)
23. Yamada T, Tsuda M, Ohba Y, Kawaguchi H, Totsuka Y, Shindoh M: PTHrP promotes malignancy of human oral cancer cell downstream of the EGFR signaling. Biochem Biophys Res Commun 2008, 368: 575-581
24. Leibbrandt A, Penninger JM: RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 2008, 1143:123-150
25. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593 (Pubitemid 37328925)
26. Roodman GD: Mechanisms of bone metastasis. N Engl J Med 2004, 350:1655-1664
27. Inuzuka T, Tsuda M, Kawaguchi H, Ohba Y: Transcription factor 8 activates R-Ras to regulate angiogenesis. Biochem Biophys Res Commun 2009, 379:510-513
28. Inuzuka T, Tsuda M, Tanaka S, Kawaguchi H, Higashi Y, Ohba Y: Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis. Cancer Res 2009, 69:1678-1684
29. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H: Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983, 51:2175-2180 (Pubitemid 13106840)
30. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108: 193-199
31. Cui N, Nomura T, Noma H, Yokoo K, Takagi R, Hashimoto S, Okamoto M, Sato M, Yu G, Guo C, Shibahala T: Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. Clin Cancer Res 2005, 11:2713-2719 (Pubitemid 40569473)
32. Nomura T, Shibahara T, Katakura A, Matsubara S, Takano N: Establishment of a murine model of bone invasion by oral squamous cell carcinoma. Oral Oncol 2007, 43:257-262 (Pubitemid 46228010)
33. Suda T, Jimi E, Nakamura I, Takahashi N: Role of 1 alpha,25- dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol 1997, 282:223-235 (Pubitemid 27412778)
34. Montesano R, Schaller G, Orci L: Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 1991, 66:697-711 (Pubitemid 121001705)
35. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176 (Pubitemid 28180851)
36. Takahashi N, Udagawa N, Suda T: A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 1999, 256:449-455 (Pubitemid 29301126)
37. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998, 95:3597-3602
38. Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-829 (Pubitemid 351757205)
39. Shintani Y, Wheelock MJ, Johnson KR: Phosphoinositide-3 kinase- Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells. Mol Biol Cell 2006, 17:2963-2975 (Pubitemid 43993501)
40. Kim YM, Lee YM, Kim HS, Kim JD, Choi Y, Kim KW, Lee SY, Kwon YG: TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 2002, 277:6799-6805 (Pubitemid 34953061)
41. Maio M, Coral S, Fratta E, Altomonte M, Sigalotti L: Epigenetic targets for immune intervention in human malignancies. Oncogene 2003, 22:6484-6488 (Pubitemid 37372328)
42. Nicholaou T, Ebert L, Davis ID, Robson N, Klein O, Maraskovsky E, Chen W, Cebon J: Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. Immunol Cell Biol 2006, 84:303-317
43. Suri A: Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 2006, 6:379-389
44. Taki M, Verschueren K, Yokoyama K, Nagayama M, Kamata N: Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase- 2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int J Oncol 2006, 28:487-496
45. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A: The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2:84-89
46. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2:76-83
47. De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G: The transcription factor Snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005, 65:6237-6244 (Pubitemid 40994409)
48. Takkunen M, Grenman R, Hukkanen M, Korhonen M, García de Herreros A, Virtanen I: Snail-dependent and -independent epithelialmesenchymal transition in oral squamous carcinoma cells. J Histochem Cytochem 2006, 54:1263-1275 (Pubitemid 44623347)
49. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R, Nagayama M: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 2001, 37:65-71
50. Hollier BG, Evans K, Mani SA: The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia 2009, 14:29-43
51. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 2009, 26:433-446
52. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715 (Pubitemid 351636299)
53. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3:e2888
54. Nagano O, Saya H: Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004, 95:930-935 (Pubitemid 40089583)
55. Ponta H, Sherman L, Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003, 4:33-45 (Pubitemid 36077255)
56. Allen CT, Ricker JL, Chen Z, Van Waes C: Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007, 29:959-971
57. Choi S, Myers JN: Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008, 87:14-32
58. Ferris RL, Grandis JR: NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Clin Cancer Res 2007, 13:5663-5664 (Pubitemid 47583889)
59. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO: Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 2002, 24:792-799 (Pubitemid 34857307)
60. Pries R, Nitsch S, Wollenberg B: Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 2006, 6:1195-1203
61. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM: Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004, 64:55-63 (Pubitemid 38114082)
62. Ziober AF, Patel KR, Alawi F, Gimotty P, Weber RS, Feldman MM, Chalian AA, Weinstein GS, Hunt J, Ziober BL: Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res 2006, 12:5960-5971 (Pubitemid 44703755)
63. Todd R, Wong DT: Epidermal growth factor receptor (EGFR) biology and human oral cancer. Histol Histopathol 1999, 14:491-500 (Pubitemid 29159018)
64. Lin TH, Rosales C, Mondal K, Bolen JB, Haskill S, Juliano RL: Integrinmediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem 1995, 270:16189-16197
65. Narayanan R, Higgins KA, Perez JR, Coleman TA, Rosen CA: Evidence for differential functions of the p50 and p65 subunits of NFkappa B with a cell adhesion model. Mol Cell Biol 1993, 13:3802-3810 (Pubitemid 23157317)
66. Qwarnström EE, Ostberg CO, Turk GL, Richardson CA, Bomsztyk K: Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol Chem 1994, 269:30765-30768 (Pubitemid 24377554)
67. Sokoloski JA, Sartorelli AC, Rosen CA, Narayanan R: Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood 1993, 82:625-632 (Pubitemid 23206131)
68. Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prévost N, Tarin D, Shattil SJ, Cheresh DA: An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med 2009, 15:1163-1169